The Stock Nobody's Talking About Could Be This Year's Winner
Many investors chase headline names, but a quiet stock nobody's talking about could surge as AI, data, and systems de...
Saving money doesn't mean you have to sacrifice your lifestyle. Discover creative ways to save while still enjoying what you love.
21,148 articlesMany investors chase headline names, but a quiet stock nobody's talking about could surge as AI, data, and systems de...
Axsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
A tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
Harrow Health's Q1 2026 earnings transcript offers more than numbers—it reveals management's execution plan and what ...
This article breaks down the factors shaping JACK's Q2 2026 earnings, from menu pricing and digital growth to cost ma...
A notable fund liquidated its entire Ascendis Pharma stake, signaling a strategic rotation in a volatile biotech sect...
The trillion-dollar club is expanding, and a few ahead-of-the-curve signals can help you spot the next member. This g...
Last year, a notable fintech stock faced a sharp decline. A major fund then exited a $4 million stake, signaling a sh...
As toyota's challenging u.s. business tests the automaker, investors watch for strategies that could yield a Maverick...
Coinbase launches three new perpetual contracts that track MarketVector AI, Defense, and China indexes, giving trader...
A former Tesla president outlines a disciplined framework that helped scale Tesla during critical years, offering pra...
A fresh modeling study puts the economic toll of long COVID at over $8 billion from 2025 to 2027, driven largely by l...